Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Mattevi

Showing results (171-180 of 201) with videos related to

Pageof 21
Sort By:
European Journal of Human Genetics : EJHG|February 16, 2017
MCM5: a new actor in the link between DNA replication and Meier-Gorlin syndromeAnnalisa Vetro, Salvatore Savasta, Annalisa Russo Raucci, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell StudiesSergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.
ACS Infectious Diseases|July 2, 2025
Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of <i>Schistosoma mansoni</i>Emanuele Fabbrizi, Gebremedhin Solomon Hailu, A Ganesan, et al.
European Journal of Medicinal Chemistry|September 1, 2014
Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1APaola Vianello, Oronza A Botrugno, Anna Cappa, et al.
Journal of Medicinal Chemistry|June 20, 2025
Enhancing Selectivity and Potency of S<sub>N</sub>Ar Covalent Inhibitors of NADPH Oxidase EnzymesBlessing C Ogboo, Kishan B Patel, Marta Massari, et al.
Science Advances|April 15, 2020
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiationRoberto Ravasio, Elena Ceccacci, Luciano Nicosia, et al.
Journal of Medicinal Chemistry|December 26, 2015
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor AgentPaola Vianello, Oronza A Botrugno, Anna Cappa, et al.
Journal of Medicinal Chemistry|March 5, 2025
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB InhibitorBeatrice Noce, Sara Marchese, Marta Massari, et al.
ACS Chemical Biology|June 1, 2013
Protein recognition by short peptide reversible inhibitors of the chromatin-modifying LSD1/CoREST lysine demethylaseMarcello Tortorici, Maria Teresa Borrello, Maria Tardugno, et al.
Iscience|July 20, 2022
Fine-tuned KDM1A alternative splicing regulates human cardiomyogenesis through an enzymatic-independent mechanismVeronica Astro, Gustavo Ramirez-Calderon, Roberta Pennucci, et al.
Pageof 21

Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
European Journal of Human Genetics : EJHG|February 16, 2017
MCM5: a new actor in the link between DNA replication and Meier-Gorlin syndromeAnnalisa Vetro, Salvatore Savasta, Annalisa Russo Raucci, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell StudiesSergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.
ACS Infectious Diseases|July 2, 2025
Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of <i>Schistosoma mansoni</i>Emanuele Fabbrizi, Gebremedhin Solomon Hailu, A Ganesan, et al.
European Journal of Medicinal Chemistry|September 1, 2014
Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1APaola Vianello, Oronza A Botrugno, Anna Cappa, et al.
Journal of Medicinal Chemistry|June 20, 2025
Enhancing Selectivity and Potency of S<sub>N</sub>Ar Covalent Inhibitors of NADPH Oxidase EnzymesBlessing C Ogboo, Kishan B Patel, Marta Massari, et al.
Science Advances|April 15, 2020
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiationRoberto Ravasio, Elena Ceccacci, Luciano Nicosia, et al.
Journal of Medicinal Chemistry|December 26, 2015
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor AgentPaola Vianello, Oronza A Botrugno, Anna Cappa, et al.
Journal of Medicinal Chemistry|March 5, 2025
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB InhibitorBeatrice Noce, Sara Marchese, Marta Massari, et al.
ACS Chemical Biology|June 1, 2013
Protein recognition by short peptide reversible inhibitors of the chromatin-modifying LSD1/CoREST lysine demethylaseMarcello Tortorici, Maria Teresa Borrello, Maria Tardugno, et al.
Iscience|July 20, 2022
Fine-tuned KDM1A alternative splicing regulates human cardiomyogenesis through an enzymatic-independent mechanismVeronica Astro, Gustavo Ramirez-Calderon, Roberta Pennucci, et al.
Pageof 21